DAVENPORT & Co LLCDAVENPORT & Co LLC

Institutional investor · Portfolio as of Q1 2019

Top Holdings653 positions

Checking export access…
Activity:
6.1M$284M3.5%——
1 qtr
First report
0

MARKEL CORP

277,601$276.6M3.4%$996.240.00%
1 qtr
First report
0
AMTAMT
REIT

American Tower Corporation

996,063$196.3M2.4%$164.080.00%
1 qtr
First report
0

Johnson & Johnson

1.4M$189.1M2.4%$113.770.00%
1 qtr
First report
0

Microsoft Corp.

1.4M$168M2.1%$110.120.00%
1 qtr
First report
0

CAPITAL ONE FINL CORP

2.1M$167.8M2.1%$71.900.00%
1 qtr
First report
0

Merck & Co., Inc

1.9M$154.2M1.9%$63.020.00%
1 qtr
First report
0

JPMorgan Chase & Co.

1.4M$138.7M1.7%$82.700.00%
1 qtr
First report
0

FIDELITY NATIONAL FINANCIAL

3.8M$137.4M1.7%$25.350.00%
1 qtr
First report
0

CITIGROUP INC

2M$127.2M1.6%$48.260.00%
1 qtr
First report
0

CARMAX INC

1.8M$126.9M1.6%$69.800.00%
1 qtr
First report
0

MARATHON PETE CORP

2M$121M1.5%$47.630.00%
1 qtr
First report
0

Berkshire Hathaway Inc.

575,008$115.5M1.4%$200.890.00%
1 qtr
First report
0
BUDBUD
ADR

ANHEUSER BUSCH INBEV SA NV SPONSORED ADR

1.4M$114.9M1.4%$76.250.00%
1 qtr
First report
0

Visa Inc

733,077$114.5M1.4%$148.120.00%
1 qtr
First report
0

DOMINION ENERGY INC

1.4M$107.2M1.3%$55.850.00%
1 qtr
First report
0

WATSCO INC

717,890$102.8M1.3%$113.580.00%
1 qtr
First report
0

MONDELEZ INTL INC

2M$100.2M1.2%$41.310.00%
1 qtr
First report
0

Danaher Corporation

753,021$99.4M1.2%$112.950.00%
1 qtr
First report
0

PEPSICO INC

806,148$98.8M1.2%$96.970.00%
1 qtr
First report
0
$8B
AUM
653
Positions
Q1 2019
Filing
HI score · 3.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
Q1'19

First report: nothing earlier to compare

Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

DAVENPORT & Co LLC manages $8B across 653 positions as of Q1 2019. Top holdings: BAM/A (3.5%), MKL (3.4%), AMT (2.4%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.

Q1 2019 Summary

First quarter we have for this fund: 653 positions, nothing earlier to compare. No standout high-conviction moves this quarter. Portfolio: $8.0B across 653 positions.

Top holdings by portfolio weight

Total AUM$8B
BAM/A3.54%
MKL3.45%
AMT2.45%
JNJ2.36%
MSFT2.09%
COF2.09%
MRK1.92%
JPM1.73%
FNF1.71%
C1.59%
Other1.58%

Portfolio allocation by GICS sector

Sectors11
Financial Services17.85%
Unknown13.06%
Healthcare10.39%
Technology9.69%
Industrials8.85%
Consumer Cyclical8.24%
Consumer Defensive7.99%
Communication Services6.24%
Real Estate5.67%
Energy5.44%
Other6.59%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Financial Services, Unknown, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L62
Conviction35
Concentration27
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
AMLPAMLPALPS ETF TR
Q4 2024 → Q2 2026+140,066 shares+$7.5M
7Q
FRFRTYTHE ALGER ETF TRUST
Q4 2024 → Q2 2026+20,833 shares+$614,021
7Q
FLVFLVAMERICAN CENTY ETF TR
Q4 2024 → Q2 2026+4,536 shares+$410,358
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used